πŸ‡ΊπŸ‡Έ FDA
Patent

US 6436629

Modulating angiogenesis

expired A61KA61K2039/505A61K31/198

Quick answer

US patent 6436629 (Modulating angiogenesis) held by The Regents of the University of California expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K31/198, A61K31/381, A61K31/405